Cosentyx (Secukinumab) Injection – 150 mg/mL
IL-17A inhibitor for psoriasis, PsA, and ankylosing spondylitis.
Description
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It targets IL-17A, a cytokine involved in systemic inflammation. Self-administered via injection.
Reviews (0)
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.